Companies

Cellular Goods launches UK’s first CBG face serum

CBG has anti-inflammatory and antioxidant properties.

Cellular Goods face serum launched following release of white paper
Home / Cellular Goods launches UK’s first CBG face serum

The UK-based brand Cellular Goods has launched its CBG face serum following the release of its recent white paper.

The face serum, which uses biosynthetic cannabinoids, will be sold on Amazon and the Cellular Goods website. The development of the product has been informed by the findings of the company’s white paper, which demonstrated that CBG has anti-inflammatory and antioxidant properties.

As the product uses lab-made CBG, it does not require the cultivation of the plant and contains 0 per cent THC.

CEO of Cellular Goods, Anna Chokina, commented: “We are thrilled to be revolutionising the wellness industry with the launch of the UK’s first CBG-powered skincare serum.

“CBG has demonstrated antioxidant and anti-inflammatory properties that qualify it as an ingredient of the future with immense potential for skincare solutions designed to prevent the signs of aging.

Read more: Cellular Goods appoints Anna Chokina as CEO

“Developing science-backed products is at the heart of what we do, and this has enabled us to offer customers a skincare product that can deliver the same or better results as traditional age prevention products without the uncomfortable side effects associated with some popular active ingredients.

“As a sensitive skin consumer, I am excited about the prospect of giving more people access to the age preventing solutions of the future, such as our exclusive Rejuvenating Serum.

“We look forward to continuing to use science to develop truly innovative products that offer tangible benefits to our consumers.

“The launch of our serum strengthens Cellular’s existing product line-up and expands our consumer offering, which coupled with the visibility generated by our increased sales channels, will help drive sales.”

Read more: Cellular Goods sign agreement for launch of ingestible CBD products

Cellular Goods has said that the products works to prevent the signs of aging caused by UV-light exposure and inflammation, and that it will allow the company to meet demand for products that have demonstrated effectiveness in addressing the signs of aging without causing harmful side effects, such as irritation and photosensitivity, that industry standard active ingredients retinol and Vitamin C can produce.

The company highlights that the serum has gone through an extensive testing process and is fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved.

[activecampaign form=31]

Topicscannabinoidscannabis industryCannabis productsuk

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · Companies

Helius Therapeutics to Supply New Phase 2 Cannabis Sleep Trial

Ben Stevens · 20 October 2026

More